Abstract
The development of immunotherapy in hematologic malignancies has been observed in the last few years. One of the approaches is the use of cancer vaccines based on leukemia-derived dendritic cells (DC). Recent studies from our laboratory and other laboratories have shown that CD40 stimulation improves leukemia cells immunogenicity and generates an antitumor immune response. The design of future cancer vaccines requires the knowledge concerning the function of dendritic cells including antigen processing. The aim of our present study was the assessment of antigen-processing machinery (APM) components in acute lymphoblastic leukemia (ALL) cells before and after CD40 stimulation at messenger RNA (mRNA) level. Twenty-five children with ALL were enrolled into the study. Leukemic cells were stimulated (or not) with CD40L and IL-4. Elements of the antigen-processing machinery (MB1, LMP2, LMP7, LMP10, TAP1, TAP2, calnexin, calreticulin, tapasin, ERp57, zeta, delta) were determined by real-time PCR technique. The expression of important costimulatory and adhesion molecules considered as DC markers (CD40, CD54, CD80, CD83, CD86) were determined at the mRNA (PCR) and protein (flow cytometry) levels. The following are the results of our study: (1) We noted an upregulation of all costimulatory and adhesion molecules at the mRNA and protein levels in ALL cells after the culture; (2) the significant rise in expression of nearly all APM components after CD40 stimulation was observed. This confirms specific stimulation of the antigen-processing system in ALL cells by CD40L. Future work should focus on the clinical significance of these findings for immunotherapy in leukemias.
Similar content being viewed by others
Abbreviations
- ALL:
-
acute lymphoblastic leukemia
- APM:
-
antigen processing machinery
- beta2M:
-
beta2-microglobulin
- CAL:
-
calnexin
- DC:
-
dendritic cells
- EBV:
-
Ebstein–Barr virus
- ER:
-
endoplasmic reticulum
- LMP:
-
low-molecular-mass polypeptide
- TAP:
-
transporter associated with antigen presentation
- TNFR:
-
tumor necrosis factor receptor
References
D’Amico G, Marin V, Biondi A (2004) Potential use of CD40 ligand for immunotherapy of childhood B-cell precursor acute lymphoblastic leukaemia. Best Pract Res Clin Haematol 17:465–477
Łuczyński W, Stasiak-Barmuta A, Iłendo E, Krawczuk-Rybak M, Malinowska I, Mitura-Lesiuk M, Parfieńczyk A, Szymański A (2006) CD40 stimulation induces differentiation of acute lymphoblastic leukemia cells into dendritic cells. Acta Biochim Pol 53:377–382
D’Amico G, Vulcano M, Bugarin C, Bianchi G, Pirovano G, Bonamino M, Marin V, Allavena P, Biagi E, Biondi A (2004) CD40 activation of BCP–ALL cells generates IL-10-producing, IL-12 defective APCs that induce allogeneic T-cell anergy. Blood 104:744–751
Łuczyński W, Iłendo E, Kovalchuk O, Krawczuk-Rybak M, Malinowska I, Kołtan A, Szczepański T, Wysocka J, Jaworowski R, Olejnik I, Chyczewski L, Matysiak M, Wysocki M, Sońta-Jakimczyk D, Wieczorek M (2006) Acute lymphoblastic leukemia cells express CCR7 but not higher amounts of IL-10 after CD40 ligation. Scand J Clin Lab Invest 66:695–704
Abele R, Tampe R (2006) Modulation of the antigen transport machinery TAP by friends and enemies. FEBS Lett 580:1156–1163
Ritz U, Momburg F, Pilch H, Huber C, Maeurer MJ, Seliger B (2001) Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma. Int J Oncol 19:1211–1220
Atkins D, Ferrone S, Schmahl GE, Storkel S, Seliger B (2004) Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma? J Urol 171:885–889
Romero JM, Jimenez P, Cabrera T, Cozar JM, Pedrinaci S, Tallada M, Garrido F, Ruiz-Cabello F (2005) Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA–ABC loss in bladder cancer. Int J Cancer 113:605–610
Facoetti A, Nano R, Zelini P, Morbini P, Benericetti E, Ceroni M, Campoli M, Ferrone S (2005) Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors. Clin Cancer Res 11:8304–8311
Frisan T, Zhang QJ, Levitskaya J, Coram M, Kurilla MG, Masucci MG (1996) Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt’s lymphoma cells. Int J Cancer 68:251–258
Dutta N, Gupta A, Mazumder DN, Banerjee S (2006) Down-regulation of locus-specific human lymphocyte antigen class I expression in Epstein–Barr virus-associated gastric cancer: implication for viral-induced immune evasion. Cancer 106:1685–1693
Ressing ME, Keating SE, van Leeuwen D, Koppers-Lalic D, Pappworth IY, Wiertz EJ, Rowe M (2005) Impaired transporter associated with antigen processing-dependent peptide transport during productive EBV infection. J Immunol 174:6829–6838
Claus JA, Brady MT, Lee J, Donohue KA, Sait SN, Ferrone S, Wetzler M (2006) T-cell activation by t(9;22) acute lymphoblastic leukemia-derived dendritic cells is associated with increased tapasin expression. Cancer Immunol Immunotheras 55:160–165
Ghia P, Transdico P, Veiga JP, Schaniel C, Sallusto F, Matsushima K, Sallan SE, Rolink AG, Mantovani A, Nadler LM, Cardoso AA (2001) Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells. Blood 98:533–540
Seliger B, Schreiber K, Delp K, Meissner M, Hammers S, Reichert T, Pawlischko K, Tampe R, Huber C (2001) Downregulation of the constitutive tapasin expression on human tumor cells of distinct origin and its transcriptional upregulation by cytokines. Tissue Antigens 57:39–45
Whiteside TL, Stanson J, Shurin MR, Ferrone S (2004) Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells. J Immunol 173:1526–1534
Tourkova IL, Shurin GV, Chatta GS, Perez L, Finke J, Whiteside TL, Ferrone S, Shurin MR (2005) Restoration by IL-15 of MHC class I antigen-processing machinery in human dendritic cells inhibited by tumor-derived gangliosides. J Immunol 175:3045–3052
Raffaghello L, Prigione I, Bocca P, Morandi F, Camoriano M, Gambini C, Wang X, Ferrone S, Pistoia V (2005) Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications. Oncogene 24:4634–4644
Satoh E, Mabuchi T, Satoh H, Asahara T, Nukui H, Naganuma H (2006) Reduced expression of the transporter associated with antigen processing 1 molecule in malignant glioma cells, and its restoration by interferon–gamma and –beta. J Neurosurg 104:264–271
Lopez-Albaitero A, Nayak JV, Ogino T, Machandia A, Gooding W, de Leo AB, Ferrone S, Ferris RL (2006) Role of antigen-processing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL. J Immunol 176:3402–3409
Lou Y, Vitalis TZ, Basha G, Cai B, Chen SS, Choi KB, Jeffries AP, Elliott WM, Atkins D, Seliger B, Jefferies WA (2005) Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival. Cancer Res 65:7926–7933
Alimonti J, Zhang QJ, Gabathuler R, Reid G, Chen SS, Jefferies WA (2000) TAP expression provides a general method for improving the recognition of malignant cells in vivo. Nat Biotechnol 18:515–520
Lin CT, Chang TC, Chao A, Dzeng E, Soong YK, Hung CF, Lai CH (2005) Enhancement of DNA vaccine potency through linkage of antigen gene to ER chaperone molecules, ER-60, tapasin, and calnexin. J Biomed Sci 12:279–287
Yang T, Lapinski PE, Zhao H, Zhou Q, Zhang H, Raghavan M, Liu Y, Zheng P (2005) A rare transporter associated with antigen processing polymorphism overpresented in HLAlow colon cancer reveals the functional significance of the signature domain in antigen processing. Clin Cancer Res 11:3614–3623
Agrawal S, Reemtsma K, Bagiella E, Oluwole SF, Braunstein NS (2004) Role of TAP-1 and/or TAP-2 antigen presentation defects in tumorigenicity of mouse melanoma. Cell Immunol 228:130–137
Norbury CC, Princiotta MF, Bacik I, Brutkiewicz RR, Wood P, Elliott T, Bennink JR, Yewdell JW (2001) Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo. J Immunol 166:4355–4362
Dissanayake SK, Tuera N, Ostrand-Rosenberg S (2005) Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome. J Immunol 174:1811–1819
van Hall T, Wolpert EZ, van Veelen P, Laban S, van der Veer M, Roseboom M, Bres S, Grufman P, de Ru A, Meiring H, deJong A, Franken K, Teixeira A, Valentijn R, Drijfhout JW, Konig F, Camps M, Ossendorp F, Karre K, Ljunggren HG, Melief CJ, Offringa R (2006) Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nat Med 12:417–424
Turnquist HR, Kohlgraf KG, McIlhaney MM, Mosley RL, Hollingsworth MA, Solheim JC (2004) Tapasin decreases immune responsiveness to a model tumor antigen. J Clin Immunol 24:462–470
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Łuczyński, W., Kowalczuk, O., Iłendo, E. et al. Upregulation of antigen-processing machinery components at mRNA level in acute lymphoblastic leukemia cells after CD40 stimulation. Ann Hematol 86, 339–345 (2007). https://doi.org/10.1007/s00277-007-0256-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-007-0256-z